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Introduction: Delirium is associated with impaired outcome, but it is unclear whether this relationship is limited to
in-hospital outcomes and whether this relationship is independent of the severity of underlying conditions. The aim
of this study was to investigate the association between delirium in the intensive care unit (ICU) and long-term
mortality, self-reported health-related quality of life (HRQoL), and self-reported problems with cognitive functioning
in survivors of critical illness, taking severity of illness at baseline and throughout ICU stay into account.
Methods: A prospective cohort study was conducted. We included patients who survived an ICU stay of at least a
day; exclusions were neurocritical care patients and patients who sustained deep sedation during the entire ICU
stay. Delirium was assessed twice daily with the Confusion Assessment Method for the ICU (CAM-ICU) and
additionally, patients who received haloperidol were considered delirious. Twelve months after ICU admission, data on
mortality were obtained and HRQoL and cognitive functioning were measured with the European Quality of Life – Six
dimensions self-classifier (EQ-6D). Regression analyses were used to assess the associations between delirium and the
outcome measures adjusted for gender, type of admission, the Acute Physiology And Chronic Health Evaluation IV
(APACHE IV) score, and the cumulative Sequential Organ Failure Assessment (SOFA) score throughout ICU stay.
Results: Of 1101 survivors of critical illness, 412 persons (37%) had been delirious during ICU stay, and 198 (18%) died
within twelve months. When correcting for confounders, no significant association between delirium and long-term
mortality was found (hazard ratio: 1.26; 95% confidence interval (CI) 0.93 to 1.71). In multivariable analysis, delirium was
not associated with HRQoL either (regression coefficient: −0.04; 95% CI −0.10 to 0.01). Yet, delirium remained associated
with mild and severe problems with cognitive functioning in multivariable analysis (odds ratios: 2.41; 95% CI 1.57 to
3.69 and 3.10; 95% CI 1.10 to 8.74, respectively).
Conclusions: In this group of survivors of critical illness, delirium during ICU stay was not associated with long-term
mortality or HRQoL after adjusting for confounding, including severity of illness throughout ICU stay. In contrast,
delirium appears to be an independent risk factor for long-term self-reported problems with cognitive functioning.Introduction
Because of improved medical care, the number of inten-
sive care unit (ICU) survivors has increased consider-
ably, but recent studies demonstrate that ICU survivors
can experience substantial long-term morbidity [1-5]. To
further improve care for survivors of critical illness, it is
important to elucidate which factors increase the risk of* Correspondence: a.e.wolters@umcutrecht.nl
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unless otherwise stated.long-term morbidity and mortality. Delirium, character-
ized by an acute change in attention and cognition, is a
common disorder in ICU patients [6-8]. Previous studies
have consistently found that delirium in the ICU is asso-
ciated with long-term mortality and cognitive impair-
ment [9-14]. It is, however, unclear whether delirium
also affects long-term health related quality of life
(HRQoL). HRQoL is defined as health, in the medical
definition, but also as the importance of independent
physical, social and emotional functioning [15]. Two
studies suggest that delirium is a risk factor for lowerl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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is no association [11,16].
However, the relationship of delirium with long-term
outcome is complex and affected by several confounding
factors [17]. Previous studies adjusted for severity of
illness at baseline, but only one investigation additionally
adjusted for severity of illness during the ICU stay [10],
which is another potentially important determinant of
long-term outcome [18]. In that study, delirium was found
to increase the risk of long-term cognitive impairment,
independent of the burden of disease during the entire
ICU stay [10]. It is currently unclear to what extent the
associations between delirium and long-term mortality and
HRQoL are confounded by severity of illness throughout
the course of the ICU stay.
We conducted a large prospective cohort study of a
diverse population of ICU survivors to assess the associ-
ation between delirium in the ICU and long-term mor-
tality, self-reported HRQoL and self-reported problems
with cognitive functioning, while adjusting for important
confounding factors such as severity of illness at baseline
and throughout the course of the ICU stay. We hypothe-
sized that persons who were delirious during their ICU
stay had worse long-term outcomes compared to indi-
viduals who were not delirious.Materials and methods
Study design
We performed a prospective cohort study within a larger
follow-up investigation of all patients admitted to the
ICU of the University Medical Center Utrecht (UMCU) in
the Netherlands. The Medical Research Ethics Committee
of the UMCU approved this study and waived the need to
ask for informed consent (protocol 10/006), since the ob-
jective of the follow-up investigation was continuous qual-
ity assessment and evaluation of regular patient care.Study population
We included all patients who were admitted to the
ICU of the UMCU for more than 24 hours, between
July 2009 and August 2011. We excluded neurotrauma,
neurosurgery and neurology patients, because the sen-
sitivity of the Confusion Assessment Method for the
ICU (CAM-ICU) is less reliable in patients with neuro-
logical disorders [7]. In this investigation, we aimed to
study mortality and morbidity in ICU survivors; there-
fore, we excluded all patients who died during their
ICU stay. Additionally, we excluded patients who had
a sustained Richmond Agitation Sedation Scale (RASS)
of −4 or −5, as delirium screening could not be con-
ducted in these patients. Furthermore, we excluded all
subjects who had no data on Sequential Organ Failure
Assessment (SOFA) scores.To determine which subjects were alive one year after
ICU admission, the hospital information system and the
Dutch municipal database were consulted. Individuals
who could not be traced were excluded. Non-survivors
were defined as all persons known to have died after dis-
charge from the ICU during the one-year follow-up
period.
Measurements during ICU stay
The Acute Physiology and Chronic Health Evaluation IV
(APACHE IV) was registered for every patient in the
ICU after the first 24 hours of admission as an estimate
of baseline severity of illness. In addition, SOFA was
scored three times daily for the entire ICU length of stay
and the cumulative score was used to provide an esti-
mate of severity of illness throughout the course of the
ICU stay. To calculate the cumulative SOFA score, we
summed all daily SOFA scores without the central ner-
vous system component, as this is altered in delirium
and otherwise analyses would be subject to overcorrec-
tion. The cumulative SOFA score was considered a bet-
ter measure than the mean or maximum SOFA score as
it better represents the burden of illness over the entire
ICU stay. We conducted sensitivity analyse using the
mean SOFA and maximal SOFA in the analysis of the
primary outcome, mortality. The presence of delirium
was assessed twice daily by bedside nurses using the
CAM-ICU, in the morning and evening shift [19]. Fur-
ther, the administration of haloperidol was considered.
Delirium during the ICU stay was defined as at least one
positive CAM-ICU and/or administration of haloperidol
during the ICU stay. In our clinic, haloperidol was not
prescribed prophylactically during this study and, there-
fore, could be used as an indicator of delirium [20].
Outcomes
The primary outcome was mortality in survivors of crit-
ical illness within the first year after ICU admission,
while adjusting for important confounding factors, such
as severity of illness at baseline and throughout the
course of their ICU stay. Secondary outcomes were self-
reported HRQoL and self-reported problems with cogni-
tive functioning, one year after ICU admission, adjusted
for the same confounders. To assess mortality, we used
all available information, including the hospital informa-
tion system and the Dutch municipal database. Persons
who survived up to one year after admission to the ICU
received a postal questionnaire to assess their physical
and psychological well-being. Phone calls were made to
all persons who did not reply to the survey, to increase
the response rate. Non-responders were all subjects who
received a survey but did not return or did not fill in the
survey. The questionnaire included the Dutch European
Quality of Life – Six Dimensions self-classifier (EQ-6D),
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six dimensions. Every dimension consists of one item,
subdivided into three levels (no, mild and severe) [21].
To assess HRQoL, we analyzed the first five questions of
the Dutch EQ-6D which corresponds to the validated
Dutch European Quality of Life – Five Dimensions self-
classifier (EQ-5DTM) [21,22]. We used a validated syntax
to calculate the EQ-5DTM index [22-24]. For assessment
of problems with cognitive functioning we used the sixth
question of the EQ-6D questionnaire [21].
Statistical analysis
For categorical data a Chi-square test was used. To
assess whether or not continuous data were normally dis-
tributed, a Q-Q plot was made and a Kolmogorov-Smirnov
test was conducted. For normally distributed, continuous
data, a Student T-test was used, and values presented as
means and standard deviations (SD). Skewed, continuous
data were studied with the Mann–Whitney U test and pre-
sented as medians with interquartile ranges (IQR).
To study the association between delirium and mortal-
ity, Cox proportional hazard regression analyses were
used, and a hazard ratio (HR) was computed. HRQoL
was compared between persons who had been delirious
and those who had not been delirious during their ICU
stay, using multivariable linear regression, which is pre-
sented as a regression coefficient. The HRQoL in these
two groups was also compared with the HRQoL norma-
tive scores of the general Dutch population. Problems
with cognitive functioning were subdivided into no prob-
lems, mild problems and severe problems. Multinomial
logistic regression was performed to quantify the associationFigure 1 Study flow chart. ICU: Intensive Care Unit; RASS: Richmond Agitbetween delirium and problems with cognitive functioning,
and data are presented as odds ratio (OR).
In the analyses on mortality, HRQoL, and problems with
cognitive functioning, the following two models were ap-
plied: 1. Model 1 did not contain additional covariates and
was used for unadjusted analyses; 2. in model 2, adjustments
were made for gender, type of admission, the APACHE IV
score and the cumulative SOFA score during the entire ICU
stay. Age is part of the APACHE IV score and was, there-
fore, not additionally entered in the model. By using the
cumulative SOFA score, indirect correction for length
of stay was made. Statistical significance was defined at
a P value less than 0.05. The Statistical Package for Social
Sciences 20.0 (SPSS 20.0) was used for all statistical analyses.
Results
Between July 2009 and August 2011, 4,294 patients were
admitted to the ICU, of whom 2,254 subjects stayed for
less than one day. In addition, 519 neurocritical care pa-
tients were excluded. Of the remaining 1,521 subjects,
205 died during their ICU stay and 5 remained comatose
during their ICU stay. Missing information about SOFA
scores, or missing information in Dutch municipal data-
base registration, resulted in the exclusion of another
210 subjects. Therefore, the final study population con-
sisted of 1,101 persons, of whom 412 (37%) were deliri-
ous during their ICU stay (Figure 1). No patients were
classified as delirious based on the prescription of halo-
peridol alone. After hospital discharge, 650 (59%) of the
subjects could return home.
Characteristics of the study population are outlined in
Table 1. Subjects who were excluded based on missingation Sedation Scale; SOFA: Sequential Organ Failure Assessment.
Table 1 ICU characteristics of the study population
Variables All patients (n = 1,101) No delirium (n = 689) Delirium (n = 412) P-value
Age (mean years, SD) 59.8 (16.5) 59.4 (16.6) 60.5 (16.7) 0.29
Male (number, %) 677 (61.5) 406 (58.9) 271 (65.8) 0.03
APACHE IV score (mean, SD) 61.3 (29.2) 53.9 (22.4) 73.7 (28.3) <0.001
CumSOFA score (median, IQR) 40.0 (19.0 to 99.0) 27.0 (13.0 to 50.5) 99.0 (47.0 to 207.0) <0.001
ICU length of stay (median days, IQR) 4.0 (3.0 to 8.0) 3.0 (2.0 to 5.0) 8.0 (5.0 to 15.0) <0.001
Type of admission
Medical (number, %) 430 (39.1) 208 (30.2) 222 (53.9) <0.001
Elective surgical (number, %) 447 (40.6) 351 (50.9) 96 (23.3)
Acute surgical (number, %) 224 (20.3) 130 (18.9) 94 (22.8)
APACHE IV: Acute Physiology and Chronic Health Evaluation IV; CumSOFA: cumulative Sequential Organ Failure Assessment without the central nervous system
component; IQR: interquartile range; SD: standard deviation.
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to delirium frequency, age, gender, APACHE IV or type
of admission. The length of stay of the study population
was longer than that of the subjects excluded due to
missing data (median 4.0, IQR 3.0 to 7.0, P = 0.01).
Persons who were delirious during their ICU stay dif-
fered from subjects who did not have delirium during
their ICU stay in gender, severity of illness scores, ICU
length of stay and type of admission (Table 1). One year
after ICU admission, 903 of the 1,101 subjects (82%)
were known to have survived. Because of an administra-
tive error, 16 individuals who appeared still alive did not
receive a questionnaire, and, therefore, 887 surveys were
sent. The response rate was 64% (571/887). After ICU
admission, the median time until the surveys were sent
back was 420 days after discharge (IQR 402 to 444 days).
In total, 198 patients died during follow-up, with a
median duration of 62 days after ICU admission (IQR 25
to 181 days). Univariate survival analysis showed that
delirious patients had a significantly increased risk of
death in the year following ICU admission. However,
when adjustments were made for the confounders de-
scribed above, delirium was no longer independently as-
sociated with mortality (Table 2).
In univariate analysis, patients with delirium during
their ICU stay had a significantly lower HRQoL score atTable 2 Risk of death associated with delirium in





Crude 1.91 (1.44 to 2.52) <0.001
Adjusted for gender, APACHE IV, type
of admission and CumSOFA
1.26 (0.93 to 1.71) 0.14
198 patients died within one year. Delirious: n = 102, not delirious: n = 96.
APACHE IV: Acute Physiology and Chronic Health Evaluation IV; CI: confidence
interval; CumSOFA: cumulative Sequential Organ Failure Assessment without
central nervous system component; ICU: intensive care unit.follow-up than patients who did not have delirium. After
adjustment for confounders, again the difference between
the two groups was no longer statistically significant
(Table 3). The assumption of homoscedasticity was veri-
fied by plotting the residuals against the fitted values.
Compared to the general Dutch population, both pa-
tient groups scored lower on the EQ-5DTM. Persons
without delirium in the ICU scored 0.85 (IQR 0.72 to
1.00) and subjects with ICU delirium scored 0.75 (IQR
0.69 to 1.00). In comparison, the estimated average
EQ-5DTM index for the general Dutch population is
0.87 (IQR 0.82 to 1.00) [24].
Persons who had been delirious during their ICU stay
experienced significantly more mild and more severe
self-reported problems in cognitive functioning com-
pared to subjects who did not have delirium in the ICU.
The strength of this association did not weaken and
remained statistically significant when adjustments were
made for confounding variables (Table 4).
To verify whether the effect measure for mortality was
robust when using the cumulative SOFA, we conducted
sensitivity analyse where we made Cox proportional haz-
ard models with the mean SOFA and the maximal SOFA
scores. Furthermore, we evaluated the effect of adding
length of stay to these models. Other variables were left
unchanged. The HRs for death in these models remainedTable 3 Differences in health-related quality of life between
delirious and non-delirious ICU survivors, within one year
after ICU admission
Model Difference, 95% CI P-value
Crude −0.06 (−0.10 to −0.01) 0.01
Adjusted for gender, APACHE IV, type
of admission and CumSOFA
−0.04 (−0.10 to 0.01) 0.09
Data on health-related quality of life was available for 546 patients. Delirious:
n = 182, not delirious: n = 364. APACHE IV: Acute Physiology and Chronic
Health Evaluation IV; CI: confidence interval; CumSOFA: cumulative Sequential
Organ Failure Assessment without central nervous system component; ICU:
intensive care unit.
Table 4 Risk of problems with cognitive functioning associated with delirium in survivors of critical illness, within one
year after ICU admission
Model OR for mild problems with
cognitive functioning, 95% CI
P-value OR for severe problems with
cognitive functioning, 95% CI
P-value
Crude 2.02 (1.39 to 2.94) <0.001 2.93 (1.16 to 7.42) 0.02
Adjusted for gender, APACHE IV,
type of admission, and CumSOFA
2.41 (1.57 to 3.69) <0.001 3.10 (1.10 to 8.74) 0.03
Data on cognitive functioning were available for 561 patients. The delirium group (n = 188) was divided into: No problems (n = 99), mild problems (n = 79) and
severe problems (n = 10). For the group without delirium (n = 373): no problems (n = 261), mild problems (n = 103) and severe problems (n = 9). APACHE IV: Acute
Physiology and Chronic Health Evaluation IV; CI: confidence interval; CumSOFA: cumulative Sequential Organ Failure Assessment without central nervous system
component; ICU: intensive care unit; OR: odds ratio.
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and length of stay is not a mediator in the causal path-
way between delirium and mortality.
Discussion
We studied the association between delirium in the ICU
and long-term mortality, HRQoL, and problems with cog-
nitive functioning in survivors of critical illness. We found
that delirium was not associated with mortality and
HRQoL when adjustments were made for confounding.
By contrast, subjects who had delirium during their ICU
stay experienced more problems with cognitive function-
ing at follow-up than persons who did not have delirium
in the ICU. The latter finding remained statistically signifi-
cant when we adjusted for confounders, including esti-
mates of severity of illness throughout the course of the
ICU stay.
To the best of our knowledge, our study is the first to
adjust for severity of illness throughout the course of the
ICU stay, in analyzing the association between delirium
with long-term mortality and HRQoL. Previous studies
on these issues adjusted for severity of illness at baseline
only [11-14,16]. Next to correction for severity of illness,
differences with previous studies could be the result of
differences in case mix, as we included ICU survivors
only. Nevertheless, our study findings emphasize that
the burden of illness during ICU stay should be taken
into account. For example, a patient after elective sur-
gery may have a low predicted mortality. However, when
such a patient develops septic shock during their ICU
stay, the risk of mortality may change but this is not in-
corporated in the APACHE IV score. Therefore, severity
of illness at admission should not be considered the sole
predictor of long-term outcome. To adjust for severity
of illness throughout the course of the ICU stay, we used
the cumulative SOFA score, which is dependent on both
the duration and the extent of multi-organ failure, and
which is strongly associated with long-term mortality
[18]. We conducted sensitivity analyse with the mean
SOFA and maximal SOFA, which showed that our effect
measure was robust.
The association that we found between delirium in the
ICU and long-term problems with cognitive functioningis consistent with a recent study, in which adjustments
for severity of illness throughout the course of the ICU
stay were made in a similar manner [10]. Factors that
precipitate delirium may thus provoke events that con-
tribute to the development or acceleration of cognitive
impairment, even when delirium is no longer present. It
would be interesting to see whether this holds only for
persistent delirium or also for rapidly reversible, sedation-
related delirium [25]. Unfortunately, we were not able to
distinguish between these types of delirium.
The evidence of no association between delirium and
long-term mortality and HRQoL should not be used as
an excuse to neglect delirium in the ICU. With our
study we show again that delirium is associated with
prolonged cognitive problems [9-11]. Interventions aimed
at reducing delirium incidence may eventually lead to
long-term beneficial effects on cognitive outcome.
It is remarkable that the self-reported cognitive prob-
lems do not seem to have an impact on patients’ self-
reported quality of life in this population. An association
between more cognitive problems and a lower HRQoL
would be expected. It might be due to a rather limited
HRQoL survey. However, our findings are consistent
with previous studies in which more extensive tools were
used to assess HRQoL and cognitive functioning, namely
the ShortForm 36 and the Cognitive Failure Question-
naire [11]. Perhaps the expectation to find a lower HRQoL
in subjects with more cognitive problems is not always
applicable.
No a priori sample size calculation was performed.
However, this is one of the largest studies so far to ad-
dress this problem. We believe that our study population
was large enough to study this issue. Nevertheless, our
study has several limitations. Due to missing data a rela-
tively large group had to be excluded, which may have
introduced bias. Excluded subjects had a shorter length
of ICU stay than the study population and did not differ
in other measured characteristics. Therefore, if selection
bias would have occurred, we have analyzed a more se-
vere group of subjects. Secondly, the sensitivity of the
CAM-ICU in daily practice may be low [7]. Yet, in con-
trast to studies where sensitivity of the CAM-ICU was
studied at one point in time, we used all CAM-ICU
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sult, we may have increased the sensitivity of the test, al-
though this was not formally assessed [26]. We also used
the prescription of haloperidol as a proxy measurement
to reduce the risk of misclassification [20]. Thirdly, the
duration of delirium as a measure for delirium burden is
an important factor to incorporate in analyses [10],
which was unfortunately not possible in our study.
Fourthly, because of the lack of baseline assessment, it
remains unclear from our data to what extent long-
term cognitive problems are caused by delirium, and
to what extent patients who experienced a delirium in
the ICU had lower cognitive functioning before admis-
sion [17]. In a recent study on delirium and long-term
cognitive impairment, this problem was addressed using
the IQCODE for patients older than 50 years, excluding
patients who were found to have severe dementia and
stratifying according to age and burden of coexisting ill-
ness. This did not alter the observation that delirium in-
creases the risk of long-term cognitive impairment [10].
Also, the response rate of the questionnaire was relatively
low, which may have led to misclassification. Unfortu-
nately, we were not able to address the issue of selective
responsiveness. Furthermore, the assessment of problems
with cognitive functioning with the EQ-6D is not detailed
enough to examine specific functions or subdomains. The
measure for cognitive functioning is based on a self-
reported three-level multiple choice question, which is
minimal compared to extensive neuropsychological test-
ing. However, because of self-reporting, the test measures
how subjects experience their cognitive functioning, which
is a relevant outcome in daily practice. Finally, the possi-
bility of bias due to unmeasured confounders cannot be
excluded, as with any observational study.
Conclusions
Delirium during ICU stay is not independently associ-
ated with long-term mortality and health related quality
of life in ICU survivors when corrected for factors such
as severity of illness throughout the course of the ICU
stay. In contrast, delirium in the ICU increases the risk
of long-term problems with cognitive functioning, inde-
pendent of severity of illness during the ICU stay.
Key messages
 In survivors of critical illness, delirium during their
ICU stay is not related to mortality or long-term
health related quality of life after adjusting for
confounding, including severity of illness throughout
the course of the ICU stay.
 ICU delirium appears to be an independent risk
factor for self-reported long-term problems with
cognitive functioning in ICU survivors.Abbreviations
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